Showing results (531-540 of 2,709) with videos related to

Sort By:
Pageof 271
Fundamental & Clinical Pharmacology|January 29, 2021
Tramadol-induced hypoglycemia: A pharmacovigilance studyClaire De Canecaude, Vanessa Rousseau, Agnès Sommet, et al.
Fundamental & Clinical Pharmacology|January 19, 2021
Antibiotics with therapeutic effects on spinal cord injury: a reviewKhashayar Afshari, Nazanin Momeni Roudsari, Naser-Aldin Lashgari, et al.
Fundamental & Clinical Pharmacology|February 4, 2021
Can chronopharmacology improve the therapeutic management of neurological diseases?Benoit Sion, Mélina Bégou
Fundamental & Clinical Pharmacology|September 11, 2019
Refining the therapeutic range of posaconazole and isavuconazole for efficient therapeutic drug monitoring using a bioassay approachThéo Willeman, Julia Tonini, Cécile Garnaud, et al.
Fundamental & Clinical Pharmacology|January 23, 2021
The contributions of metabolomics in the discovery of new therapeutic targets in Alzheimer's diseaseRayhanatou Altiné-Samey, Daniel Antier, Sylvie Mavel, et al.
Fundamental & Clinical Pharmacology|April 23, 2014
The AMPA receptor antagonist perampanel is a new hope in the treatment for epilepsyEhab S El Desoky
Fundamental & Clinical Pharmacology|April 4, 2017
Curcuma decreases serum hepcidin levels in healthy volunteers: a placebo-controlled, randomized, double-blind, cross-over studyFabrice Lainé, Bruno Laviolle, Edouard Bardou-Jacquet, et al.
Fundamental & Clinical Pharmacology|November 25, 2018
A nanoparticle-coupled T2 peptide induces immune tolerance and ameliorates chronic prostatitis/chronic pelvic pain syndrome (CP/CPPS) in mice modelYanfang Cao, Yijie Cheng, Awais Ullah Ihsan, et al.
Fundamental & Clinical Pharmacology|February 19, 2019
Real-world insights into risk of developing cardiovascular disease following GnRH agonists versus antagonists for prostate cancer: a methodological protocol to a study using five European databasesGincy George, Lucie-Marie Scailteux, Hans Garmo, et al.
Fundamental & Clinical Pharmacology|January 1, 1987
Effect of peptidyl-dipeptidase inhibitors in experimental convulsions in miceF J Miñano, J S Serrano, M Sancibrián, et al.
Pageof 271